NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Brinton Pharmaceuticals

Brinton Pharmaceuticals

Private
PuneHealthcare & Life Scienceshttps://brintonhealth.com/

Last Round

Debt

Sep 16, 2020

Est. Valuation

$25M

Total Funding Raised

$13.36M

Company Overview

Brinton Pharmaceuticals is a pharmaceutical company that provides clinical and cosmetic dermatology formulations intended to cure skin and hair problems.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Fashion & Beauty

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

pharmaceuticalsdermatologypharma companypharma formulationsIndian pharmacosmetic dermatologysunscreenpediatricsnutraceuticalsfootcarepharmaceutical manufacturinggastroenterologyrespiratory careD2C wellness

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Brinton Pharmaceuticals Comparables

Compare Brinton Pharmaceuticals with similar companies based on industry and business-model similarity.

Brinton Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Brinton Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtSep 16, 2020
Series BJun 17, 2019
Series AMay 4, 2017
View all Funding Rounds

Key People

Founding team and executive leadership

G Sathya

Chief Executive Officer South Asia South East Asia

Executive Team

Chandra Prakash Singh

Chief Financial Officer

Executive Team

Alok Kumar Das

Executive Board Member & Chief People Officer, Chief People Officer

Executive Team

Brinton Pharmaceuticals Investors

Notable investors and investment history

Brinton Pharmaceuticals investors
InvestorRounds
Tata Capital Healthcare FundSeries A
Marigold CapitalSeries A
BlackSoilDebt
India Alternatives Investment AdvisorsSeries B
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 10, 2025

    Monthly visitors increased 654% MoM to 30.9K.

  • May 2, 2025

    Monthly visitors increased 58% MoM, reaching 8.4K.

View all signals

Brinton Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Brinton Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Brinton Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersPune
Employee Range730
Year Founded2013
Last FundingSep 16, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.